SCHEMBL19185408

SCHEMBL19185408

CCOC(C)(C)CCNC(=O)CCN1C(=O)CC(S)C1=O

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.31
▸ TSHR P16473 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ HDAC3 O15379 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC7 Q8WUI4 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31
▸ HDAC10 Q969S8 1/20 0.31
▸ HDAC11 Q96DB2 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ HDAC9 Q9UKV0 1/20 0.31
▸ HDAC5 Q9UQL6 1/20 0.31
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20705909 0.91 HPGD (0.33) HPGDHTTSMN1; SMN2HDAC3HDAC4
SCHEMBL20926880 0.88 HPGD (0.33) HPGDHTTSMN1; SMN2ALDH1A1HSD17B10
SCHEMBL19928723 0.87 HPGD (0.33) HPGDHTTSMN1; SMN2ALDH1A1HSD17B10
SCHEMBL18431336 0.85 ALDH1A1 (0.32) HPGDHTTSMN1; SMN2ALDH1A1HSD17B10
SCHEMBL23056737 0.85 HSD17B10 (0.34) HPGDHTTSMN1; SMN2ALDH1A1HSD17B10
SCHEMBL19721671 0.84 — —
SCHEMBL23226171 0.81 TP53 (0.41) HPGDHTTSMN1; SMN2HSD17B10POLB
SCHEMBL18612787 0.81 FOLH1 (0.35) HPGDSMN1; SMN2ALDH1A1HSD17B10TSHR
SCHEMBL18867883 0.81 FOLH1 (0.35) HPGDSMN1; SMN2ALDH1A1HSD17B10TSHR
SCHEMBL23397424 0.80 ALDH1A1 (0.39) HPGDHTTSMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11092594-B2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use VENTANA MEDICAL SYSTEMS, INC. (US) 2021-08-17 — — US disclosed
US-20180120306-A1 HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE VENTANA MED SYST INC (US) 2018-05-03 — — US disclosed
US-9719986-B2 Haptens, hapten conjugates, compositions thereof preparation and method for their preparation and use VENTANA MEDICAL SYSTEMS, INC. (US) 2017-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180120306-A1 HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE CRBN, AHR, RORB HPGD 1803/4885HTT 1772/4885SMN1; SMN2 4647/4885
US-11092594-B2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use CRBN, AHR, RORB HPGD 1803/4885HTT 1772/4885SMN1; SMN2 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback